HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Dolton Selected Research

astegolimab

1/2022Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe Asthma.
10/2021Population repeated time-to-event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires.
1/2021Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Dolton Research Topics

Disease

3Asthma (Bronchial Asthma)
01/2022 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2020
1Wounds and Injuries (Trauma)
06/2010
1Burns
06/2010
1Infections
06/2010

Drug/Important Bio-Agent (IBA)

3astegolimabIBA
01/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2021
1tau Proteins (tau Protein)IBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022
1Interleukin-33IBA
01/2021
1AlarminsIBA
01/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1AllergensIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2020
1crenezumabIBA
01/2020
1CreatinineIBA
06/2010
1VancomycinFDA LinkGeneric
06/2010

Therapy/Procedure

1Biological Therapy
01/2021